MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
1-Year Return
38.15%
This Quarter Return
+17.61%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$556M
AUM Growth
+$28.1M
(+5.3%)
Cap. Flow
-$35.9M
Cap. Flow
% of AUM
-6.46%
Top 10 Holdings %
Top 10 Hldgs %
17.22%
Holding
230
New
38
Increased
44
Reduced
92
Closed
35
Top Buys
| 1 |
The Bancorp
TBBK
|
$7.18M |
| 2 |
Light & Wonder
LNW
|
$6.85M |
| 3 |
e.l.f. Beauty
ELF
|
$5.07M |
| 4 |
ESCO Technologies
ESE
|
$4.49M |
| 5 |
Freshworks
FRSH
|
$4.48M |
Top Sells
| 1 |
Kinsale Capital Group
KNSL
|
$10.5M |
| 2 |
HealthEquity
HQY
|
$6.56M |
| 3 |
Cytokinetics
CYTK
|
$5.39M |
| 4 |
Hilton Grand Vacations
HGV
|
$5.06M |
| 5 |
Allete
ALE
|
$4.77M |
Sector Composition
| 1 | Financials | 17.18% |
| 2 | Healthcare | 16.22% |
| 3 | Technology | 15.16% |
| 4 | Industrials | 13.74% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Alnylam Pharmaceuticals
ALNY
$59.4B
| $629K | 0.11% |
3,285
+1,002
| +44% | +$192K |
|
127
Exact Sciences
EXAS
$10.2B
| $627K | 0.11% |
8,477
+2,996
| +55% | +$222K |
|
128
Celldex Therapeutics
CLDX
$1.55B
| $582K | 0.1% |
14,687
| – | – |
|
129
East-West Bancorp
EWBC
$14.8B
| $579K | 0.1% |
8,054
-18
| -0.2% | -$1.3K |
|
130
UnitedHealth
UNH
$286B
| $573K | 0.1% |
1,088
-50
| -4% | -$26.3K |
|
131
Bio-Techne
TECH
$8.4B
| $490K | 0.09% |
6,351
+2,576
| +68% | +$199K |
|
132
Stryker
SYK
$150B
| $486K | 0.09% |
1,622
-153
| -9% | -$45.8K |
|
133
Blackstone
BX
$132B
| $483K | 0.09% |
3,687
+30
| +0.8% | +$3.93K |
|
134
JPMorgan Chase
JPM
$814B
| $481K | 0.09% |
2,828
+187
| +7% | +$31.8K |
|
135
Gilead Sciences
GILD
$142B
| $475K | 0.09% |
5,858
| – | – |
|
136
Deckers Outdoor
DECK
$18B
| $465K | 0.08% |
4,170
-2,982
| -42% | -$332K |
|
137
Incyte
INCY
$16.8B
| $463K | 0.08% |
7,371
| – | – |
|
138
PepsiCo
PEP
$201B
| $454K | 0.08% |
2,676
+485
| +22% | +$82.4K |
|
139
Teledyne Technologies
TDY
$25.5B
| $447K | 0.08% |
1,001
-1
| -0.1% | -$446 |
|
140
United Therapeutics
UTHR
$17.6B
| $445K | 0.08% |
2,024
| – | – |
|
|
141
Kinsale Capital Group
KNSL
$10.6B
| $437K | 0.08% |
1,304
-31,226
| -96% | -$10.5M |
|
142
Broadridge
BR
$29.2B
| $427K | 0.08% |
2,076
+5
| +0.2% | +$1.03K |
|
143
Stifel
SF
$11.5B
| $426K | 0.08% |
6,161
-17
| -0.3% | -$1.18K |
|
144
AppFolio
APPF
$10.1B
| $423K | 0.08% |
+2,441
| New | +$423K |
|
145
Boston Scientific
BSX
$159B
| $421K | 0.08% |
7,285
-516
| -7% | -$29.8K |
|
146
Xenon Pharmaceuticals
XENE
$3.04B
| $420K | 0.08% |
9,123
| – | – |
|
147
Pool Corp
POOL
$12.3B
| $417K | 0.08% |
1,046
-2
| -0.2% | -$797 |
|
148
Advanced Drainage Systems
WMS
$11.4B
| $410K | 0.07% |
2,912
-8
| -0.3% | -$1.13K |
|
149
Pultegroup
PHM
$27.8B
| $408K | 0.07% |
+3,956
| New | +$408K |
|
150
Alphabet (Google) Class A
GOOGL
$2.83T
| $401K | 0.07% |
2,874
| – | – |
|